Cheung, Y Whitney <br/><br/>
Post-thrombotic syndrome in patients treated with rivaroxaban or enoxaparin/vitamin K antagonists for acute deep-vein thrombosis. A post-hoc analysis.  [electronic resource] 

 -  Thrombosis and haemostasis  Sep 2016 
 - 733-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>2567-689X 
<br/><br/><label>Standard No.: </label>10.1160/TH16-01-0041  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Anticoagulants--therapeutic use<br/>Enoxaparin--therapeutic use<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Male<br/>Middle Aged<br/>Postthrombotic Syndrome--epidemiology<br/>Recurrence<br/>Rivaroxaban--therapeutic use<br/>Survival Analysis<br/>Treatment Outcome<br/>Venous Thrombosis--drug therapy<br/>Vitamin K--antagonists & inhibitors